CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
+0.61%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$467M
AUM Growth
+$467M
(-21%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-26.17%
Top 10 Holdings %
Top 10 Hldgs %
26.44%
Holding
967
New
165
Increased
72
Reduced
65
Closed
251
Top Buys
| 1 |
WWE
World Wrestling Entertainment
WWE
|
$11.2M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$10.9M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
$10.8M |
| 4 |
Walt Disney
DIS
|
$10.3M |
| 5 |
UBS Group
UBS
|
$10.2M |
Top Sells
| 1 |
PMT
PennyMac Mortgage Investment
PMT
|
$17.9M |
| 2 |
Antero Resources
AR
|
$17.5M |
| 3 |
Teck Resources
TECK
|
$17.2M |
| 4 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$15.1M |
| 5 |
EQT Corp
EQT
|
$14.5M |
Sector Composition
| 1 | Healthcare | 21.87% |
| 2 | Technology | 15.34% |
| 3 | Consumer Discretionary | 10.92% |
| 4 | Communication Services | 9.1% |
| 5 | Financials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Abercrombie & Fitch
ANF
$4.35B
| – | – |
0
| – | – |
|
952
American Outdoor Brands
AOUT
$131M
| – | – |
0
| – | – |
|
953
APA Corp
APA
$8.11B
| – | – |
-242,900
| Closed | -$11.3M |
|
954
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-17,000
| Closed | -$879K |
|
955
Apollo Global Management
APO
$75.9B
| – | – |
0
| – | – |
|
956
Appian
APPN
$2.28B
| – | – |
0
| – | – |
|
957
Digital Turbine
APPS
$455M
| – | – |
0
| – | – |
|
|
958
Antero Resources
AR
$9.82B
| – | – |
-565,079
| Closed | -$17.5M |
|
959
Ares Capital
ARCC
$15.7B
| – | – |
0
| – | – |
|
960
Arcturus Therapeutics
ARCT
$467M
| – | – |
0
| – | – |
|
961
Ardelyx
ARDX
$1.57B
| – | – |
0
| – | – |
|
962
Ares Management
ARES
$38.8B
| – | – |
0
| – | – |
|
963
argenx
ARGX
$44.2B
| – | – |
0
| – | – |
|
964
ARK Innovation ETF
ARKK
$7.43B
| – | – |
0
| – | – |
|
965
Alliance Resource Partners
ARLP
$2.95B
| – | – |
-43,800
| Closed | -$890K |
|
966
Archrock
AROC
$4.42B
| – | – |
-12,400
| Closed | -$111K |
|
967
Arcutis Biotherapeutics
ARQT
$1.91B
| – | – |
0
| – | – |
|